Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Key Players companies in Hemoperfusion
by Most Literature Citation in the China in 2020

The Hemoperfusion top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Literature Citation Hemoperfusion Key Players in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2020, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Hemoperfusion or hæmoperfusion (see spelling differences) is a method of filtering the blood extracorporeally (that is, outside the body) to remove a toxin. As with other extracorporeal methods, such as hemodialysis (HD), hemofiltration (HF), and hemodiafiltration (HDF), the blood travels from the patient into a machine, gets filtered, and then travels back into the patient, typically by venovenous access (out of a vein and back into a vein).
#
Company Name
Region
Tech Topics
Total
1
Tianjin Medical University General Hospital
Literature citation: 29
2
Jen Ai Hospital
Literature citation: 16
3
Chinese People's Liberation Army General Hospital
Medical school,Oncology drugs,Cancer immunotherapy,
...[+2]
Literature citation: 5
4
Tianjin First Center Hospital
Literature citation: 5
5
Guangdong General Hospital
Cell therapy,Genetic engineering,Messenger RNA,
...[+2]
Literature citation: 4
Page generation time: Jul 20 2025